📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
77
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
38%
💰 Capital Raise
55%
• Critical: only 2.8 months cash remaining
📜 Warrant Exercise
25%
• Significant warrants: 20% of shares outstanding
🔄 Reverse Split
15%
• Only 3 months cash — financial pressure
💹 Market Data
Market Cap$18.57M
Shares Outstanding5.38M
Float2.05M
Cash$2.20M
Debt$355.0K
Short InterestN/A
🏛 Institutional Holdings
1 institutional holders · 3 shares
#1
CoreCap Advisors, LLC
3 shares
📉 Short Interest
Short Interest55.3K
Days to Cover1.0
% of Float2.7%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NCEL
📊 NCEL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NCEL Signal Convergence & Dark Pool Activity — StonkWhisper
📄 NCEL Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.